Atlas Trials

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

Clinical trial NCT00995332 · COMPLETED

Trial details

NCT number
NCT00995332
Sponsor
University of Bergen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous Leukemia
Start date
2009-09-01
Primary completion
2013-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.